During a live event, Xiuning Le, MD, PhD, discussed clinical trials of supportive care for infusion reaction and skin rash ...

I’m really sad that my life is in the hands of these decision-makers who seem to make these decisions in such a cold way.” ...

Investigators are using MET immunohistochemistry testing and FDA-approved profiling tools to personalize care and address ...

Efti plus Keytruda and chemo achieved a 61% response rate in first-line advanced non-squamous non–small cell lung cancer, ...

Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center, discusses some of the recent trends in cancer ...

Higher-than-usual doses of radiation in the treatment of inoperable lung cancer can be safely combined with immunotherapy ...

With lung tumour cases on the rise in India, robotic-assisted thoracic surgery offers a breakthrough—providing faster ...

A study published in Scientific Reports reveals a significant prevalence of mental health concerns among Vietnamese family ...

A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to ...

Novel combination achieves 60.8% response rate and 90.2% disease control rate in first-line non-small cell lung cancer (1L ...

The RAPID-RT method shows that it’s possible to test new treatment ideas faster and with more patients than ever before. It’s ...